Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal
Clinical trial NCT03584308 · COMPLETED
Trial details
- NCT number
- NCT03584308
- Sponsor
- Catalysis SL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-15
- Primary completion
- 2018-05-15
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.